| PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
NMUR2 |
NMUR2, NMU2R, TGR1: Neuromedin-U receptor 2 |
0.667 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
RELB |
RELB: Transcription factor RelB |
0.667 |
Evidence |
|
| PBX2 |
PBX2, G17: Pre-B-cell leukemia transcription factor 2 |
MLX |
MLX, TCFL4: Max-like protein X |
0.667 |
Evidence |
|
| DRD3 |
DRD3: D(3) dopamine receptor |
ADRA2A |
IPI00031712 |
0.667 |
Evidence |
|
| CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
SMURF2 |
SMURF2: E3 ubiquitin-protein ligase SMURF2 |
0.667 |
Evidence |
|
| SSTR3 |
SSTR3: Somatostatin receptor type 3 |
RXFP1 |
IPI00719123 |
0.667 |
Evidence |
|
| SSTR3 |
SSTR3: Somatostatin receptor type 3 |
DRD3 |
DRD3: D(3) dopamine receptor |
0.667 |
Evidence |
|
| CCKAR |
CCKAR, CCKRA: Cholecystokinin receptor type A |
OR51B4 |
OR51B4: Olfactory receptor 51B4 |
0.667 |
Evidence |
|
| CCKAR |
CCKAR, CCKRA: Cholecystokinin receptor type A |
OR51E1 |
Dresden-G-protein-coupled receptor |
0.667 |
Evidence |
|
| HNRPH3 |
HNRPH3: Heterogeneous nuclear ribonucleoprotein H3 |
BAT1 |
IPI00328343 |
0.667 |
Evidence |
|
| AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
BIRC3 |
BIRC3, API2, IAP1, MIHC, RNF49: Baculoviral IAP repeat-containing protein 3 |
0.667 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
CDK10 |
CDK10: Cell division protein kinase 10 |
0.667 |
Evidence |
|
| NFYB |
NFYB, HAP3: Nuclear transcription factor Y subunit beta |
TAF1L |
TAF1L: Transcription initiation factor TFIID 210 kDa subunit |
0.667 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
PMS2 |
PMS2: Postmeiotic segregation increased 2 nirs variant 1 |
0.667 |
Evidence |
|
| HNRPA2B1 |
HNRPA2B1: Heterogeneous nuclear ribonucleoproteins A2/B1 |
POLR2G |
POLR2G: DNA-directed RNA polymerase II subunit RPB7 |
0.667 |
Evidence |
|
| DRD5 |
DRD5, DRD1B, DRD1L2: D(1B) dopamine receptor |
RXFP1 |
IPI00719123 |
0.667 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
KHDRBS3 |
KHDRBS3, SALP, SLM2: KH domain-containing, RNA-binding, signal transduction-asso |
0.667 |
Evidence |
|
| CHRM3 |
CHRM3: Muscarinic acetylcholine receptor M3 |
OR51B4 |
OR51B4: Olfactory receptor 51B4 |
0.667 |
Evidence |
|
| TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
ELMO1 |
IPI00219532 |
0.667 |
Evidence |
|
| HIST1H1C |
HIST1H1C, H1F2: Histone H1.2 |
TEAD4 |
TEAD4, RTEF1, TCF13L1, TEF3: Transcriptional enhancer factor TEF-3 |
0.667 |
Evidence |
|
| RALA |
RALA, RAL: Ras-related protein Ral-A precursor |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
0.667 |
Evidence |
|
| CHRM1 |
CHRM1: Muscarinic acetylcholine receptor M1 |
ADRA2A |
IPI00031712 |
0.667 |
Evidence |
|
| CHRM1 |
CHRM1: Muscarinic acetylcholine receptor M1 |
MTNR1A |
MTNR1A: Melatonin receptor type 1A |
0.667 |
Evidence |
|
| CHRM1 |
CHRM1: Muscarinic acetylcholine receptor M1 |
LHCGR |
LHCGR, LCGR, LGR2, LHRHR: Lutropin-choriogonadotropic hormone receptor precursor |
0.667 |
Evidence |
|
| CHRM1 |
CHRM1: Muscarinic acetylcholine receptor M1 |
ADRA2B |
ADRA2B, ADRA2L1, ADRA2RL1: Alpha-2B adrenergic receptor |
0.667 |
Evidence |
|